Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review
COVID-19 pandemic waves have hit on our lives with pulmonary and, also, gastrointestinal symptoms. The latter also includes acute liver damage linked to direct SARS-CoV-2 action and/or drug-induced (DILI) in the frame of pre-existing chronic liver disease. We aimed to review literature data regardin...
Main Authors: | Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, Catia Di Giampaolo, Francesca Ponziani, Ludovico Abenavoli, Emidio Scarpellini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/4/199 |
Similar Items
-
Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
by: Hideki Mori, et al.
Published: (2022-07-01) -
Gut dysbiosis in alcoholic liver disease: Wonderful dilemma?
by: Ludovico Abenavoli, et al.
Published: (2023-09-01) -
Gut Microbiota and Liver Transplantation: Immune Mechanisms behind the Rejection
by: Ludovico Abenavoli, et al.
Published: (2023-06-01) -
Liver and COVID-19: possible mechanisms of damage
by: Marina G. Mnatsakanyan, et al.
Published: (2021-04-01) -
The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
by: Daniele Balducci, et al.
Published: (2023-06-01)